Cargando…

Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials

BACKGROUND: Guizhi Fuling pill, a famous traditional Chinese herbal formula, has been widely used for treatment of gynecological diseases. This meta-analysis sought to evaluate the add-on effect of Guizhi Fuling capsule (GZFL) to mifepristone in women with endometriosis. METHODS: A comprehensively l...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Wenbin, Ta, Na, Wang, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831320/
https://www.ncbi.nlm.nih.gov/pubmed/31415429
http://dx.doi.org/10.1097/MD.0000000000016878
_version_ 1783465942354755584
author Meng, Wenbin
Ta, Na
Wang, Fei
author_facet Meng, Wenbin
Ta, Na
Wang, Fei
author_sort Meng, Wenbin
collection PubMed
description BACKGROUND: Guizhi Fuling pill, a famous traditional Chinese herbal formula, has been widely used for treatment of gynecological diseases. This meta-analysis sought to evaluate the add-on effect of Guizhi Fuling capsule (GZFL) to mifepristone in women with endometriosis. METHODS: A comprehensively literature search was conducted using Pubed, Embase, Cochrane Library, Wanfang, CNKI, VIP databases from their inceptions to January 25, 2019. Randomized controlled trials that compared GZFL plus mifepristone to mifepristone alone for treatment of endometriosis were eligible. Main outcomes were pregnancy, reduction of the recurrence, and serum level of follicle-stimulating hormone, luteinizing hormone, estradiol or progesterone. RESULTS: A total of 1052 women with endometriosis from 10 trials were identified and analyzed. Meta-analyses showed that GZFL plus mifepristone was superior to mifepristone in reducing the recurrence of endometriosis (RR 0.40; 95% CI 0.27–0.59) and improving the pregnancy (risk ratio [RR] 1.74; 95% confidence intervals [CI] 1.40–2.17). Moreover, adjuvant treatment with GZFL also significantly reduced serum level of estradiol (mean difference [MD] −20.83 pmol/L; 95% CI −34.01 to −7.65) and progesterone (MD −0.18 mmol/L; 95% CI −0.23 to −0.12). However, there were no significant differences in serum level of follicle-stimulating hormone (MD −0.42 U/L; 95% CI −1.16 to 0.31) and luteinizing hormone (MD −0.04 U/L; 95% CI −0.43 to 0.34). CONCLUSION: GZFL as adjuvant therapy to mifepristone appears to have additional benefits in preventing recurrence of endometriosis and improving pregnancy among women with endometriosis. However, these conclusions should be interpreted with caution due to the methodological flaws of the included trials.
format Online
Article
Text
id pubmed-6831320
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68313202019-11-19 Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials Meng, Wenbin Ta, Na Wang, Fei Medicine (Baltimore) 3800 BACKGROUND: Guizhi Fuling pill, a famous traditional Chinese herbal formula, has been widely used for treatment of gynecological diseases. This meta-analysis sought to evaluate the add-on effect of Guizhi Fuling capsule (GZFL) to mifepristone in women with endometriosis. METHODS: A comprehensively literature search was conducted using Pubed, Embase, Cochrane Library, Wanfang, CNKI, VIP databases from their inceptions to January 25, 2019. Randomized controlled trials that compared GZFL plus mifepristone to mifepristone alone for treatment of endometriosis were eligible. Main outcomes were pregnancy, reduction of the recurrence, and serum level of follicle-stimulating hormone, luteinizing hormone, estradiol or progesterone. RESULTS: A total of 1052 women with endometriosis from 10 trials were identified and analyzed. Meta-analyses showed that GZFL plus mifepristone was superior to mifepristone in reducing the recurrence of endometriosis (RR 0.40; 95% CI 0.27–0.59) and improving the pregnancy (risk ratio [RR] 1.74; 95% confidence intervals [CI] 1.40–2.17). Moreover, adjuvant treatment with GZFL also significantly reduced serum level of estradiol (mean difference [MD] −20.83 pmol/L; 95% CI −34.01 to −7.65) and progesterone (MD −0.18 mmol/L; 95% CI −0.23 to −0.12). However, there were no significant differences in serum level of follicle-stimulating hormone (MD −0.42 U/L; 95% CI −1.16 to 0.31) and luteinizing hormone (MD −0.04 U/L; 95% CI −0.43 to 0.34). CONCLUSION: GZFL as adjuvant therapy to mifepristone appears to have additional benefits in preventing recurrence of endometriosis and improving pregnancy among women with endometriosis. However, these conclusions should be interpreted with caution due to the methodological flaws of the included trials. Wolters Kluwer Health 2019-08-16 /pmc/articles/PMC6831320/ /pubmed/31415429 http://dx.doi.org/10.1097/MD.0000000000016878 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 3800
Meng, Wenbin
Ta, Na
Wang, Fei
Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials
title Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials
title_full Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials
title_fullStr Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials
title_full_unstemmed Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials
title_short Add-on effect of Guizhi Fuling formula to mifepristone for endometriosis: A meta-analysis of randomized controlled trials
title_sort add-on effect of guizhi fuling formula to mifepristone for endometriosis: a meta-analysis of randomized controlled trials
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831320/
https://www.ncbi.nlm.nih.gov/pubmed/31415429
http://dx.doi.org/10.1097/MD.0000000000016878
work_keys_str_mv AT mengwenbin addoneffectofguizhifulingformulatomifepristoneforendometriosisametaanalysisofrandomizedcontrolledtrials
AT tana addoneffectofguizhifulingformulatomifepristoneforendometriosisametaanalysisofrandomizedcontrolledtrials
AT wangfei addoneffectofguizhifulingformulatomifepristoneforendometriosisametaanalysisofrandomizedcontrolledtrials